Phytochemical Name : Hispidulin

Properties Information
PhytoCAT-ID PhytoCAT-142
Phytochemical name or plant extracts Hispidulin
PMID 33552273
Literature evidence Overall, the current findings suggested that hispidulin may inhibit EMT and cell migration by suppressing the Smad2/3 signaling pathway in breast cancer cells.
IUPAC name 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxychromen-4-one
Phytochemicals’ class or type of plant extracts Flavonoid
Source of phytochemicals or plant Extracts Dittrichia viscosa
Geographical availability Albania, Algeria, Azores, Baleares, Bulgaria, Canary Is., Corse, Cyprus, East Aegean Is., Egypt, France, Greece, Italy, Kriti, Lebanon-Syria, Libya, Madeira, Morocco, Palestine, Portugal, Sardegna, Sicilia, Sinai, Spain, Tunisia, Turkey, Turkey-in-Europe, Yugoslavia
Plant parts Stem, Leaves, Flowers
Other cancers Breast cancer
Target gene or protein Vimentin , E-cadherin, occludin
Gene or Protein evidence However, hispidulin and TGF-β1 co-treatment increased the expression levels of E-cadherin and occludin, while downregulating vimentin expression. Additionally, hispidulin treatment inhibited TGF-β1-induced Smad2/3 signaling and cell migration in both breast cancer cell lines.
Target pathways Smad2/3 signaling pathway
IC50 25.44±0.23 µM against MCF-7
Potency Overall, the current findings suggested that hispidulin may inhibit EMT and cell migration by suppressing the Smad2/3 signaling pathway in breast cancer cells.
Cell line/ mice model MCF-7, HCC38
Additional information  Hispidulin treatment increased the expression levels of EMT-associated epithelial markers and decreased the expression levels of mesenchymal markers in both cells. Transforming growth factor-β1 (TGF-β1) treatment increased breast cancer cell viability (assessed via MTS assay) and EMT induction.
PubChem ID 5281628
Additional PMIDs 34015367 23561091 22537643 33552273 22418930
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:201893-1
Safety NA